title: Nonionic contrast media: economic analysis and health policy development.
abstract: The replacement of old radiologic contrast media with supposedly safer but more expensive media has created a dilemma for radiologists and hospital administrators. To quantitate the nature of this trade-off we performed a cost-utility analysis using optimistic assumptions that favoured the new media. A complete conversion to the new media would result in an incremental cost of at least $65,000 to gain 1 quality-adjusted life-year (QALY). For a selective strategy in which only high-risk patients would receive the new media the cost would be about $23,000 per QALY gained. However, the incremental cost for low-risk patients is over $220,000 per QALY gained. Conversion to the new contrast media, although not necessarily the most efficient use of scarce resources, has already occurred in Ontario, primarily because of press publicity, pressure from insurers and a political unwillingness of policymakers to decide the fate of identifiable victims. We found that funding of a new intervention associated with a high cost-utility ratio rather than interventions with lower ratios might save some identifiable victims at the expense of a larger number of unidentifiable ones.
authors.affiliation: Community Medicine Residency Program, Faculty of Medicine, University of Toronto, Ont.
authors.forename: V
authors.initials: V
authors.lastname: Goel
authors.forename: R B
authors.initials: RB
authors.lastname: Deber
authors.forename: A S
authors.initials: AS
authors.lastname: Detsky
mesh_terms: D000328:Adult; D003287:Contrast Media / Q000009:adverse effects; D003362:Cost-Benefit Analysis / Q000706:statistics & numerical data; D003663:Decision Trees; D006291:Health Policy; D006748:Hospital Departments / Q000191:economics*; D006801:Humans; D009864:Ontario; D011872:Radiology Department, Hospital / Q000191:economics*; D012307:Risk Factors; D013673:Technology Assessment, Biomedical; D026712:Value of Life
chemical_list: D003287:Contrast Media